To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Cleared position in Personalis by 95 shares, the number of shares held decreased 100% compared to the previous period and now represents 0% of the total position.
      49Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 9,465 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 1.11% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Kymera Therapeutics, Inc. by 705 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 0.82% of the total position.
      109Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Freenome, Inc. by 10,305 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 0.9% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Iambic Therapeutics by 9,730 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 1.08% of the total position.
      3Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 32,865 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 2.51% of the total position.
      18Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 1,575 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 4.2% of the total position.
      4Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 10,320 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 2.22% of the total position.
      21Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 5,250 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 1.35% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 3,465 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 1.89% of the total position.
      7Comment
      Report
       
       
       
       

      Most Discussed